Report Categories Report Categories

Report Categories

industry Category

All

Total: 3 records, 1 pages

Global Rabeprazole Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

new_biaoQian Rabeprazole Drug

According to our (Global Info Research) latest study, the global Rabeprazole Drug market size was valued at USD 221.2 million in 2023 and is forecast to a readjusted size of USD 278.6 million by 2030 with a CAGR of 3.3% during review period.

USD3480.00

Add To Cart

Add To Cart

Global Rabeprazole Drug Supply, Demand and Key Producers, 2023-2029

date 24 Feb 2023

date Pharma & Healthcare

new_biaoQian Rabeprazole Drug

Rabeprazole is a proton pump inhibitor that suppresses gastric acid production in the stomach. It has several medical uses: the management of conditions that involve excess gastric acid production (e.g. Zollinger–Ellison syndrome), conditions that are worsened by gastric acid (e.g. ulcerations of the gastrointestinal tract), and conditions involving prolonged exposure to gastric acid (e.g. symptomatic gastroesophageal reflux disease).

USD4480.00

Add To Cart

Add To Cart

Global Rabeprazole Drug Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 07 Jan 2023

date Pharma & Healthcare

new_biaoQian Rabeprazole Drug

Rabeprazole is a proton pump inhibitor that suppresses gastric acid production in the stomach. It has several medical uses: the management of conditions that involve excess gastric acid production (e.g. Zollinger–Ellison syndrome), conditions that are worsened by gastric acid (e.g. ulcerations of the gastrointestinal tract), and conditions involving prolonged exposure to gastric acid (e.g. symptomatic gastroesophageal reflux disease).

USD3480.00

Add To Cart

Add To Cart

industry 02 Jan 2024

industry Pharma & Healthcare

new_biaoQian Rabeprazole Drug

According to our (Global Info Research) latest study, the global Rabeprazole Drug market size was valued at USD 221.2 million in 2023 and is forecast to a readjusted size of USD 278.6 million by 2030 with a CAGR of 3.3% during review period.

USD3480.00

addToCart

Add To Cart

industry 24 Feb 2023

industry Pharma & Healthcare

new_biaoQian Rabeprazole Drug

Rabeprazole is a proton pump inhibitor that suppresses gastric acid production in the stomach. It has several medical uses: the management of conditions that involve excess gastric acid production (e.g. Zollinger–Ellison syndrome), conditions that are worsened by gastric acid (e.g. ulcerations of the gastrointestinal tract), and conditions involving prolonged exposure to gastric acid (e.g. symptomatic gastroesophageal reflux disease).

USD4480.00

addToCart

Add To Cart

industry 07 Jan 2023

industry Pharma & Healthcare

new_biaoQian Rabeprazole Drug

Rabeprazole is a proton pump inhibitor that suppresses gastric acid production in the stomach. It has several medical uses: the management of conditions that involve excess gastric acid production (e.g. Zollinger–Ellison syndrome), conditions that are worsened by gastric acid (e.g. ulcerations of the gastrointestinal tract), and conditions involving prolonged exposure to gastric acid (e.g. symptomatic gastroesophageal reflux disease).

USD3480.00

addToCart

Add To Cart